Victrex (OTCMKTS:VTXPF) Share Price Crosses Above Two Hundred Day Moving Average – Time to Sell?

Victrex PLC (OTCMKTS:VTXPF – Get Free Report) shares passed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $9.78 and traded as high as $12.89. Victrex shares last traded at $12.89, with a volume of 500 shares trading hands.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the stock. Jefferies Financial Group reaffirmed a “hold” rating on shares of Victrex in a research note on Friday, September 25th. Citigroup reissued a “neutral” rating on shares of Victrex in a research note on Friday, September 11th. Finally, Deutsche Bank restated a “hold” rating on shares of Victrex in a report on Thursday, September 10th. Four analysts have rated the stock with a Hold rating. According to data from MarketBeat.com, Victrex currently has a consensus rating of “Hold”.

Read Our Latest Stock Report on VTXPF

Victrex Stock Performance

The stock’s 50-day moving average price is $10.98 and its 200 day moving average price is $9.78. The company has a quick ratio of 1.04, a current ratio of 2.35 and a debt-to-equity ratio of 0.11.

Victrex Company Profile

(Get Free Report)

Victrex is a United Kingdom-based manufacturer of high-performance polymer solutions, best known for polyether ether ketone (PEEK) and related polyaryletherketone materials. The company develops and supplies polymers, semi-finished forms and components for use where durability, heat resistance or chemical resistance is important. Its products serve customers in industries including aerospace, automotive, electronics, energy, medical and industrial manufacturing. Victrex also supplies biomaterial solutions for medical applications through its Invibio business.

Further Reading

Receive News & Ratings for Victrex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Victrex and related companies with MarketBeat.com's FREE daily email newsletter.